Professor Kim Hong-bin of Bundang Seoul National University Hospital elected the next chairman of the Korean Infectious Society
Nov 15, 2024
Bundang Seoul National University Hospital was recently held by Professor Kim Hong-bin of the Department of Infectious DiseasesIt was announced on the 15th that it was elected as the next chairman of the Korean Infectious Society at the Autumn Conference of the Law Society.
Since its foundation in 1961, the Korean Society of Infectious Diseases (KSID) has led academic development in the field of infection at home and abroad, prevention of infectious diseases, diagnosis and treatment, and policy-making. In recent years, it has played a pivotal role in various fields such as recruitment of infection experts, proper use of antibiotics, and treatment of multidrug resistant bacteria.
Professor Kim Hong-bin, who will serve as the chairman of the Korean Society of Infectious Diseases for two years from 2026, is the first scholar member of the American Medical Epidemiology Association (SHEA) in Korea and is a global infectious disease expert who has served as an editor of the official journal of the American Society of Medical Epidemiology 'Antimicrobial Stewardship and Healthcare Epidemiology' and a master scholar member of the American Society of Infectious Diseases (IDSA).
In each phase of infectious diseases such as MERS and COVID-19, it played a key role in the national infection control, and in 2016, it was awarded the Green Tide Order for its contribution to preventing the spread of MERS. Recently, he was appointed as a member of the World Health Organization's Antibiotic Resistance Advisory Organization 'WHO STAG-AMR' and is working on preparing global countermeasures against the antibiotic resistance problem called 'quiet pandemic'.
Professor Kim Hong-bin said, `There are many problems that need to be more alert and quickly prepared for antibiotic resistance, which is a serious health and medical problem worldwide, such as unknown infectious diseases and severe infectious diseases such as sepsis.' `The Korean Infectious Society will take the lead in finding solutions and making efforts to reflect them in policies.'
Since its foundation in 1961, the Korean Society of Infectious Diseases (KSID) has led academic development in the field of infection at home and abroad, prevention of infectious diseases, diagnosis and treatment, and policy-making. In recent years, it has played a pivotal role in various fields such as recruitment of infection experts, proper use of antibiotics, and treatment of multidrug resistant bacteria.
Professor Kim Hong-bin, who will serve as the chairman of the Korean Society of Infectious Diseases for two years from 2026, is the first scholar member of the American Medical Epidemiology Association (SHEA) in Korea and is a global infectious disease expert who has served as an editor of the official journal of the American Society of Medical Epidemiology 'Antimicrobial Stewardship and Healthcare Epidemiology' and a master scholar member of the American Society of Infectious Diseases (IDSA).
In each phase of infectious diseases such as MERS and COVID-19, it played a key role in the national infection control, and in 2016, it was awarded the Green Tide Order for its contribution to preventing the spread of MERS. Recently, he was appointed as a member of the World Health Organization's Antibiotic Resistance Advisory Organization 'WHO STAG-AMR' and is working on preparing global countermeasures against the antibiotic resistance problem called 'quiet pandemic'.
Professor Kim Hong-bin said, `There are many problems that need to be more alert and quickly prepared for antibiotic resistance, which is a serious health and medical problem worldwide, such as unknown infectious diseases and severe infectious diseases such as sepsis.' `The Korean Infectious Society will take the lead in finding solutions and making efforts to reflect them in policies.'
|
bellho@sportschosun.com
